Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Luggage wheel housing with wheel
Systems and/or methods for determining item serial number structure and intelligence
Haworthia plant named `CAPETOWN`
Plasma panel based radiation detector
Computer program, system, and method for mapping Social Security claiming strategies
Display panel and gate driving circuit and driving method for gate driving circuit
  Randomly Featured Patents
Process for removal of organo-sulfur compounds from liquid hydrocarbons
Reformate control via accelerometer
Hydrogen supplemented diesel electric locomotive
Blade fastening means of a turbine
Motor-switch arrangement for a hand-held power tool
Human-in-the-loop machine control loop
Resource remapping in a hardware emulation environment
Methods and apparatus for inventory location compliance
Balloon perfusion catheter
Opener for threaded jar lids